Status:
COMPLETED
Factors That Affect the Development of COPD Symptoms
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death in the United States. There is no cure and the disease gets worse over time. Although it usually occurs in people ...
Detailed Description
COPD is a chronic lung disease in which the lungs' airways and balloon-like air sacs, called alveoli, are damaged, lose their shape, and become floppy. As a result, they cannot fully inflate to allow ...
Eligibility Criteria
Inclusion
- Ability to read and write in English
- Able to participate in the informed consent process
- Planned lung resection at BJH
- Acceptable pulmonary function tests done at BJH within 1 month of enrollment
- Acceptable chest CT scan done at BJH within 3 years of enrollment
Exclusion
- Pregnant
- Prisoner
- Vulnerable populations
- Clinically significant lung disease other than COPD and the indication for resection (e.g., cystic fibrosis, bronchiectasis, obliterative bronchiolitis, airway lesion)
- Coexisting active chronic inflammatory or collagen vascular disease, immune deficiency of any kind, or previous organ transplant
- Known active hepatitis B, hepatitis C, or HIV/AIDS (not prospectively evaluated)
- Systemic chemotherapy within past 1 month (30 days)
- Hematologic malignancy or thoracic radiation within past year
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00740337
Start Date
October 1 2007
End Date
February 1 2016
Last Update
June 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110